Carlsmed, Inc. (CARL)
NASDAQ: CARL · Real-Time Price · USD
9.99
-0.87 (-8.01%)
At close: Mar 20, 2026, 4:00 PM EDT
10.00
+0.01 (0.10%)
After-hours: Mar 20, 2026, 4:57 PM EDT
Carlsmed Revenue
In the year 2025, Carlsmed had annual revenue of $50.51M with 85.94% growth. Carlsmed had revenue of $15.17M in the quarter ending December 31, 2025, with 61.19% growth.
Revenue (ttm)
$50.51M
Revenue Growth
+85.94%
P/S Ratio
5.29
Revenue / Employee
$397,724
Employees
127
Market Cap
267.05M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 50.51M | 23.35M | 85.94% |
| Dec 31, 2024 | 27.17M | 13.39M | 97.16% |
| Dec 31, 2023 | 13.78M | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionCARL News
- 23 days ago - Carlsmed, Inc. (CARL) Q4 2025 Earnings Call Transcript - Seeking Alpha
- 23 days ago - Carlsmed® Reports Fourth Quarter and Full Year 2025 Financial Results - GlobeNewsWire
- 25 days ago - Carlsmed, Inc. To Participate in the 2026 Canaccord Genuity Musculoskeletal Conference - GlobeNewsWire
- 4 weeks ago - Carlsmed Announces first corra™ personalized Cervical Plating Procedure - GlobeNewsWire
- 5 weeks ago - Carlsmed Inc. to Report Fourth Quarter and Full Year 2025 Financial Results on February 25, 2026 - GlobeNewsWire
- 5 weeks ago - Carlsmed Announces First aprevo® Bi-lateral Posterior Lumbar Interbody Fusion Procedure - GlobeNewsWire
- 2 months ago - Carlsmed Announces Preliminary Revenue for the Fourth Quarter and Full Year 2025 - GlobeNewsWire
- 2 months ago - Carlsmed aprevo® Lumbar 2-year Data Published in Global Spine Journal - GlobeNewsWire